Independent agenda
Topics are set by the convenor on the evidence, in consultation with the APPG secretariat and participating researchers. No funder, sponsor or department sets the agenda or sees recommendations before they are agreed in the room.
Leadership & governance
Who runs the AMR Interface
The Interface is researcher-led and independent. It is convened by one named academic, hosted by a university rather than owned by one, and built so that the method survives the grant that started it.
2026Founded, and led by its founder
ESRCImpact Acceleration Account, current funding
In kindAll expert contributions, including the venue
PortableOwned by the researcher, not the institution
The convenor
Dr Rasha Abdelsalam Elshenawy
Senior Lecturer in Postgraduate Medicine · University of Hertfordshire
Dr Elshenawy founded and leads the AMR Interface. Her work sits at the point where antimicrobial resistance research meets policy: antimicrobial stewardship implementation, AMR surveillance, and the question of how evidence actually reaches the people who decide.
She submitted written evidence to the UK Parliament's inquiry into antimicrobial resistance, convened the May 2026 roundtable at the House of Commons, and is the author of the translation method the programme runs on. She supervises postgraduate research on AMR and stewardship, and works across UK and global health policy settings.
- Senior Lecturer in Postgraduate MedicineSchool of Health, Medicine and Life Sciences, University of Hertfordshire
- Associate EditorJAC-Antimicrobial Resistance, Oxford University Press
- Trustee and Council MemberBritish Society for Antimicrobial Chemotherapy
- Director, Antimicrobial Stewardship SchoolFADIC UK
How decisions get made
Governance
The Interface is small by design. These are the rules it runs by, and they are published here so that participants can hold it to them.
Declared interests
Every contributor declares relevant interests before speaking, and the declarations sit in the session record. Anyone with a commercial interest in a recommendation does not draft it.
Patients in the room
Lived experience is a standing part of the evidence session, not a closing remark. The patient contribution carries the same weight as the clinical and regulatory ones.
Built to outlast the grant
A portable programme
Most impact projects end when their funding does. The Interface was designed the other way round: the university hosts it, but it does not own it.
- The method is written down
The six-stage Translation Cycle is documented in a peer-reviewed paper precisely so that it can be repeated — by this programme, or by someone else in a different policy domain.
- The record is independent
The domain, the archive and the outputs sit with the programme rather than inside an institutional site, so that a change of employer does not break a single citation.
- The relationships are named
Hosts, chairs and contributors are published for every session. Nothing depends on a private contact list.
Current hosting
- HostUniversity of Hertfordshire, School of Health, Medicine and Life Sciences
- MechanismESRC Impact Acceleration Account award, administered through Policy Connect
- TermMarch to September 2026
- OwnershipThe programme, its method and its outputs remain with the founder
- ContinuityHosting can transfer without interrupting the roundtable calendar or the archive
Funding & declarations
Where the money comes from
The programme runs on a small award and a large amount of donated expertise. Both are stated here in full.
Current funding
- FunderEconomic and Social Research Council, through the Impact Acceleration Account held at the University of Hertfordshire
- Administered byPolicy Connect
- Award£5,000 [remove this line if you would rather not publish the figure]
- PeriodMarch to September 2026
- PurposeTranslating existing evidence into policy — classified as impact activity, not new research
- NextThe method and its outputs are intended to support future NIHR and MRC applications
Declarations
- CommercialNo commercial sponsorship, and no industry funding of any roundtable [confirm before publishing]
- Speaker feesNone paid. Every expert contributor gives their time without a fee
- VenueProvided in kind through the All-Party Parliamentary Group on AMR
- EditorialThe convenor is an Associate Editor at JAC-Antimicrobial Resistance and takes no part in decisions on Interface submissions to that journal
- MembershipThe convenor is a Trustee of BSAC, which contributes expertise to the programme in kind
- CorrectionsAny error in a declaration is corrected on this page and dated
Host, fund or partner the next cycle
The Interface is looking for partners for the next roundtable cycle and for the funding that carries the annual report to Parliament. Institutions, funders and professional bodies are welcome to get in touch.